11
Views
0
CrossRef citations to date
0
Altmetric
Review

Importance of complete abstinence from alcohol during pregnancy: enough evidence for justification?

&
Pages 401-414 | Published online: 10 Jan 2014

References

  • Lemoine P, Harousseau H, Borteyru J, Menuet J. Les Enfants des parents alcooliques: anomalies observes apropos de 127 cas. Ouest Med.21476–21482 (1968).
  • Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet2(7836), 999–1001 (1973).
  • Streissguth AP, O’Malley K. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin. Clin. Neuropsychiatry5(3), 177–190 (2000).
  • Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention and Treatment. National Academy Press, DC, USA (1996).
  • Barr HM, Streissguth AP, Martin DC, Herman CS. Infant size at 8 months of age: relationship to maternal use of alcohol, nicotine, and caffeine during pregnancy. Pediatrics74(3), 336–341 (1984).
  • Health Canada. Joint statement: prevention of fetal alcohol syndrome (FAS), fetal alcohol effects (FAE) in Canada. Paediatr. Child Health2(2), 143–145 (1997).
  • Smitherman CH. The lasting impact of fetal alcohol syndrome and fetal alcohol effect on children and adolescents. J. Pediatr. Health Care8(3), 121–126 (1994).
  • Streissguth AP, Barr HM, Kogan J, Bookstein FL. Understanding the Occurrence of Secondary Disabilities in Clients with Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effects (FAE). Final Report to the Centers for Disease Control and Prevention, August 1996. Technical Report 96–06. Fetal Alcohol and Drug Unit, University of Washington, Seattle, DC, USA (1996).
  • Abel EL. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol. Teratol.17(4), 437–443 (1995).
  • Abel EL, Sokol RJ. A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin. Exp. Res.15(3), 514–524 (1991).
  • Clarren SK, Randels SP, Sanderson M, Fineman RM. Screening for fetal alcohol syndrome in primary schools: a feasibility study. Teratology63(1), 3–10 (2001).
  • Miller L, Tolliver R, Druschel C et al. Fetal alcohol syndrome – Alaska, Arizona, Colorado, and New York, 1995–1997. MMWR Morb. Mortal. Wkly Rep.51(20), 433–435 (2002).
  • Weiss M, Cronk CE, Mahkorn S, Glysch R, Zirbel S. The Wisconsin Fetal Alcohol Syndrome Screening Project. WMJ103(5), 53–60 (2004).
  • Sampson PD, Streissguth AP, Bookstein FL et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology56(5), 317–326 (1997).
  • Robinson GC, Conry JL, Conry RF. Clinical profile and prevalence of fetal alcohol syndrome in an isolated community in British Columbia. CMAJ137, 203–207 (1987).
  • Williams RJ, Odaibo FS, McGee JM. Incidence of fetal alcohol syndrome in northeastern Manitoba. Can. J. Public Health90(3), 192–194 (1999).
  • May PA, Brooke L, Gossage JP et al. Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. Am. J. Public Health90(12), 1905–1912 (2000).
  • May PA, Gossage JP, Marais AS et al. The epidemiology of fetal alcohol syndrome and partial FAS in a South African community. Drug Alcohol Depend.88(2–3), 259–271 (2007).
  • Fast DK, Conry J, Loock CA. Identifying fetal alcohol syndrome among youth in the criminal justice system. J. Dev. Behav. Pediatr.20(5), 370–372 (1999).
  • May PA, Fiorentino D, Phillip GJ et al. Epidemiology of FASD in a province in Italy: prevalence and characteristics of children in a random sample of schools. Alcohol Clin. Exp. Res.30(9), 1562–1575 (2006).
  • Stade BC, Stevens B, Ungar WJ, Beyene J, Koren G. Health-related quality of life of Canadian children and youth prenatally exposed to alcohol. Health Qual. Life Outcomes4, 81 (2006).
  • Abel EL, Sokol RJ. A revised estimate of the economic impact of fetal alcohol syndrome. Recent Dev. Alcohol.9117–9125 (1991).
  • Stade B, Ali A, Bennett D et al. The burden of prenatal exposure to alcohol: revised measurement of cost. Can. J. Clin. Pharmacol.16(1), e91–e102 (2009).
  • US Department of Health and Human Services. Summary of Findings From the 1999 National Household Survey on Drug Abuse. US Department of Health and Human Services, DC, USA (2000).
  • Bearer CF. Markers to detect drinking during pregnancy. Alcohol Res. Health.25(3), 210–218 (2001).
  • Ebrahim SH, Luman ET, Floyd RL, Murphy CC, Bennett EM, Boyle CA. Alcohol consumption by pregnant women in the United States during 1988–1995. Obstet. Gynecol.92(2), 187–192 (1998).
  • Ebrahim SH, Diekman ST, Floyd RL, Decoufle P. Comparison of binge drinking among pregnant and nonpregnant women, United States, 1991–1995. Am. J. Obstet. Gynecol.180(1 Pt 1), 1–7 (1999).
  • Ebrahim SH, Decoufle P, Palakathodi AS. Combined tobacco and alcohol use by pregnant and reproductive-aged women in the United States. Obstet. Gynecol.96(5 Pt 1), 767–771 (2000).
  • Centers for Disease Control and Prevention. Alcohol use among women of childbearing age – United States, 1991–1999. JAMA287(16), 2069–2071 (2002).
  • Alcohol consumption among women who are pregnant or who might become pregnant – United States, 2002. MMWR Morb. Mortal. Wkly Rep.53(50), 1178–1181 (2004).
  • Tough S, Tofflemire K, Clarke M, Newburn-Cook C. Do Women change their drinking behaviors while trying to conceive? An opportunity for preconception counseling. Clin. Med. Res.4(2), 97–105 (2006).
  • Hamlyn B, Brooker S, Oleinikova K, Wands S. Infant Feeding Survey 2000. The Stationary Office, UK, 1–232 (2002).
  • Bailey BN, Delaney-Black V, Covington CY et al. Prenatal exposure to binge drinking and cognitive and behavioral outcomes at age 7 years. Am. J. Obstet. Gynecol.191(3), 1037–1043 (2004).
  • Barr HM, Bookstein FL, O’Malley KD, Connor PD, Huggins JE, Streissguth AP. Binge drinking during pregnancy as a predictor of psychiatric disorders on the Structured Clinical Interview for DSM-IV in young adult offspring. Am. J. Psychiatry163(6), 1061–1065 (2006).
  • Henderson J, Kesmodel U, Gray R. Systematic review of the fetal effects of prenatal binge-drinking. J. Epidemiol. Community Health61(12), 1069–1073 (2007).
  • Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low–moderate prenatal alcohol exposure on pregnancy outcome. BJOG114(3), 243–252 (2007).
  • O’Leary CM, Heuzenroeder L, Elliott EJ, Bower C. A review of policies on alcohol use during pregnancy in Australia and other English-speaking countries, 2006. Med. J. Aust.186(9), 466–471 (2007).
  • Surgeon general’s advisory on alcohol and pregnancy. FDA Drug Bull.11(2), 9–10 (1981).
  • US Department of Health and Human Services. With understanding and improving health and objectives for improving health. In: Healthy People 2010 (2nd Edition). US Government Printing Office, DC, USA (2000).
  • Alberta Medical Association. Preface to the prevention & diagnosis of fetal alcohol syndrome (FAS) Alberta Partnership on Fetal Alcohol Syndrome. In: The Alberta Clinical Practice Guidelines Program. Alberta Medical Association, AB, Canada (1999).
  • Health Canada. Prevention of Fetal Alcohol Syndrome (FAS), Fetal Alcohol Effects (FAE) in Canada. Catalog No.: H39-348/1996E. Health Canada, ON, Canada (1996).
  • US Department of Agriculture/US Department of Health and Human Services. Nutrition and Your Health: Dietary Guidelines for Americans (3rd Edition). US Department of Agriculture/US Department of Health and Human Services, DC, USA, 25–26 (1990).
  • Kelly Y, Sacker A, Gray R, Kelly J, Wolke D, Quigley MA. Light drinking in pregnancy, a risk for behavioural problems and cognitive deficits at 3 years of age? Int. J. Epidemiol.38(1), 129–140 (2009).
  • Hill AB. The environment and disease: association or causation? Proc. R. Soc. Med.58295–58300 (1965).
  • Abel EL. Fetal Alcohol Syndrome and Fetal Alcohol Effects. Plenum Press, NY, USA (1984).
  • Abel EL, Sokol RJ. Maternal and fetal characteristics affecting alcohol’s teratogenicity. Neurobehav. Toxicol. Teratol.8(4), 329–334 (1986).
  • Barr HM, Streissguth AP. Identifying maternal self-reported alcohol use associated with fetal alcohol spectrum disorders. Alcohol Clin. Exp. Res.25(2), 283–287 (2001).
  • Streissguth AP, Barr HM, Martin DC. Offspring effects and pregnancy complications related to self-reported maternal alcohol use. Dev. Pharmacol. Ther.5(1–2), 21–32 (1982).
  • Hard ML, Einarson TR, Koren G. The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure. Ther. Drug Monit.23(4), 427–434 (2001).
  • Abel EL. Maternal alcohol consumption and spontaneous abortion. Alcohol Alcohol.32(3), 211–219 (1997).
  • May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res. Health25(3), 159–167 (2001).
  • Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol.35(4), 400–410 (2000).
  • Hoyme HE, May PA, Kalberg WO et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics115(1), 39–47 (2005).
  • Astley SJ, Clarren SK. A fetal alcohol syndrome screening tool. Alcohol Clin. Exp. Res.19(6), 1565–1571 (1995).
  • Astley SJ, Clarren SK. A case definition and photographic screening tool for the facial phenotype of fetal alcohol syndrome. J. Pediatr.129(1), 33–41 (1996).
  • Streissguth AP, Barr HM, Sampson PD. Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin. Exp. Res.14(5), 662–669 (1990).
  • Astley SJ. Comparison of the 4-digit diagnostic code and the Hoyme diagnostic guidelines for fetal alcohol spectrum disorders. Pediatrics118(4), 1532–1545 (2006).
  • Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ172(5 Suppl.), S1–S21 (2005).
  • Astley SJ, Bailey D, Talbot C, Clarren SK. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: II. A comprehensive profile of 80 birth mothers of children with FAS. Alcohol. Alcohol.35(5), 509–519 (2000).
  • Baer JS, Barr HM, Bookstein FL, Sampson PD, Streissguth AP. Prenatal alcohol exposure and family history of alcoholism in the etiology of adolescent alcohol problems. J. Stud. Alcohol59(5), 533–543 (1998).
  • Baer JS, Sampson PD, Barr HM, Connor PD, Streissguth AP. A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch. Gen. Psychiatry60(4), 377–385 (2003).
  • Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin. Exp. Res.21(1), 150–161 (1997).
  • Kerns KA, Don A, Mateer CA, Streissguth AP. Cognitive deficits in nonretarded adults with fetal alcohol syndrome. J. Learn. Disabil.30(6), 685–693 (1997).
  • O’Connor MJ, Shah B, Whaley S, Cronin P, Gunderson B, Graham J. Psychiatric illness in a clinical sample of children with prenatal alcohol exposure. Am. J. Drug Alcohol Abuse28(4), 743–754 (2002).
  • Olson HC, Streissguth AP, Sampson PD, Barr HM, Bookstein FL, Thiede K. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J. Am. Acad. Child Adolesc. Psychiatry36(9), 1187–1194 (1997).
  • Puttler LI, Zucker RA, Fitzgerald HE, Bingham CR. Behavioral outcomes among children of alcoholics during the early and middle childhood years: familial subtype variations. Alcohol Clin. Exp. Res.22(9), 1962–1972 (1998).
  • Steinhausen HC, Nestler V, Spohr HL. Development of psychopathology of children with the fetal alcohol syndrome. J. Dev. Behav. Pediatr.3(2), 49–54 (1982).
  • Streissguth AP. Maternal drinking and the outcome of pregnancy: implications for child mental health. Am. J. Orthopsychiatry47(3), 422–431 (1977).
  • Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O’Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J. Dev. Behav. Pediatr.25(4), 228–238 (2004).
  • Kodituwakku PW, Handmaker NS, Cutler SK, Weathersby EK, Handmaker SD. Specific impairments in self-regulation in children exposed to alcohol prenatally. Alcohol Clin. Exp. Res.19(6), 1558–1564 (1995).
  • Kodituwakku PW, Kalberg W, May PA. The effects of prenatal alcohol exposure on executive functioning. Alcohol Res. Health25(3), 192–198 (2001).
  • Mattson SN, Riley EP, Jernigan TL et al. A decrease in the size of the basal ganglia following prenatal alcohol exposure: a preliminary report. Neurotoxicol. Teratol.16(3), 283–289 (1994).
  • Mattson SN, Riley EP, Sowell ER, Jernigan TL, Sobel DF, Lyons JK. A decrease in the size of the basal ganglia in children with fetal alcohol syndrome. Alcohol Clin. Exp. Res.20(6), 1088–1093 (1996).
  • Mattson SN, Riley EP, Delis DC, Stern C, Lyons JK. Verbal learning and memory in children with fetal alcohol syndrome. Alcohol Clin. Exp. Res.20(5), 810–816 (1996).
  • Mattson SN, Riley EP. A review of the neurobehavioral deficits in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin. Exp. Res.22(2), 279–294 (1998).
  • Mattson SN, Goodman AM, Caine C, Delis DC, Riley EP. Executive functioning in children with heavy prenatal alcohol exposure. Alcohol Clin. Exp. Res.23(11), 1808–1815 (1999).
  • Riley EP, Mattson SN, Sowell ER, Jernigan TL, Sobel DF, Jones KL. Abnormalities of the corpus callosum in children prenatally exposed to alcohol. Alcohol Clin. Exp. Res.19(5), 1198–1202 (1995).
  • Riley EP, McGee CL, Sowell ER. Teratogenic effects of alcohol: a decade of brain imaging. Am. J. Med. Genet. C Semin. Med. Genet.127(1), 35–41 (2004).
  • Roebuck TM, Mattson SN, Riley EP. A review of the neuroanatomical findings in children with fetal alcohol syndrome or prenatal exposure to alcohol. Alcohol Clin. Exp. Res.22(2), 339–344 (1998).
  • Roebuck TM, Mattson SN, Riley EP. Behavioral and psychosocial profiles of alcohol-exposed children. Alcohol Clin. Exp. Res.23(6), 1070–1076 (1999).
  • Streissguth AP. Fetal alcohol syndrome: early and long-term consequences. NIDA Res. Monogr.119, 126–130 (1992).
  • Streissguth AP, Sampson PD, Olson HC et al. Maternal drinking during pregnancy: attention and short-term memory in 14-year-old offspring – a longitudinal prospective study. Alcohol Clin. Exp. Res.18(1), 202–218 (1994).
  • Swayze VW, Johnson VP, Hanson JW et al. Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics99(2), 232–240 (1997).
  • Streissguth AP, Barr HM, Martin DC. Maternal alcohol use and neonatal habituation assessed with the Brazelton scale. Child Dev.54(5), 1109–1118 (1983).
  • Malanga CJ, Kosofsky BE. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin. Perinatol.26(1), 17–37 (1999).
  • Abel EL. Alcohol-induced changes in blood gases, glucose, and lactate in pregnant and nonpregnant rats. Alcohol13(3), 281–285 (1996).
  • Chan D, Knie B, Boskovic R, Koren G. Placental handling of fatty acid ethyl esters: perfusion and subcellular studies. J. Pharmacol. Exp. Ther.310(1), 75–82 (2004).
  • Mattson SN, Schoenfeld AM, Riley EP. Teratogenic effects of alcohol on brain and behavior. Alcohol Res. Health25(3), 185–191 (2001).
  • Menegola E, Broccia ML, Di Renzo F, Giavini E. Acetaldehyde in vitro exposure and apoptosis: a possible mechanism of teratogenesis. Alcohol23(1), 35–39 (2001).
  • Young C, Olney JW. Neuroapoptosis in the infant mouse brain triggered by a transient small increase in blood alcohol concentration. Neurobiol. Dis.22(3), 548–554 (2006).
  • Dikranian K, Qin YQ, Labruyere J, Nemmers B, Olney JW. Ethanol-induced neuroapoptosis in the developing rodent cerebellum and related brain stem structures. Brain Res. Dev. Brain Res.155(1), 1–13 (2005).
  • Wozniak DF, Hartman RE, Boyle MP et al. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol. Dis.17(3), 403–414 (2004).
  • Laposata M. Fatty acid ethyl esters: ethanol metabolites which mediate ethanol-induced organ damage and serve as markers of ethanol intake. Prog. Lipid. Res.37(5), 307–316 (1998).
  • Laposata M. Fatty acid ethyl esters: nonoxidative ethanol metabolites with emerging biological and clinical significance. Lipids34(Suppl.) S281–S285 (1999).
  • Laposata M. Fatty acid ethyl esters: current facts and speculations. Prostaglandins Leukot. Essent. Fatty Acids60(5–6), 313–315 (1999).
  • Best CA and Laposata M. Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front. Biosci., 8e202–8e217 (2003).
  • Abel EL, Hannigan JH. Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicol. Teratol.17(4), 445–462 (1995).
  • Allebeck P, Olsen J. Alcohol and fetal damage. Alcohol Clin. Exp. Res.22(7 Suppl.), 329S–332S (1998).
  • Bearer CF. Mechanisms of brain injury: L1 cell adhesion molecule as a target for ethanol-induced prenatal brain injury. Semin. Pediatr. Neurol.8(2), 100–107 (2001).
  • Hard ML, Abdolell M, Robinson BH, Koren G. Gene-expression analysis after alcohol exposure in the developing mouse. J. Lab. Clin. Med.145(1), 47–54 (2005).
  • Maier SE, West JR. Drinking patterns and alcohol-related birth defects. Alcohol Res. Health25(3), 168–174 (2001).
  • Nulman I, Rovet J, Kennedy D et al. Binge alcohol consumption by non-alcohol-dependent women during pregnancy affects child behaviour, but not general intellectual functioning; a prospective controlled study. Arch. Womens Ment. Health7(3), 173–181 (2004).
  • O’Connor MJ, Brill NJ, Sigman M. Alcohol use in primiparous women older than 30 years of age: relation to infant development. Pediatrics78(3), 444–450 (1986).
  • Olney JW, Wozniak DF, Farber NB, Jevtovic-Todorovic V, Bittigau P, Ikonomidou C. The enigma of fetal alcohol neurotoxicity. Ann. Med.34(2), 109–119 (2002).
  • Zajac CS, Abel EL. Animal models of prenatal alcohol exposure. Int. J. Epidemiol.21(Suppl.), S24–S32 (1992).
  • Khaole NC, Ramchandani VA, Viljoen DL, Li TK. A pilot study of alcohol exposure and pharmacokinetics in women with or without children with fetal alcohol syndrome. Alcohol Alcohol.39(6), 503–508 (2004).
  • Fried PA, O’Connell CM, Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J. Dev. Behav. Pediatr.13(6), 383–391 (1992).
  • Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol. Teratol.14(5), 299–311 (1992).
  • Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J. Dev. Behav. Pediatr.11(2), 49–58 (1990).
  • Fried PA and Watkinson B. 12- and 24-month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcohol. Neurotoxicol. Teratol.10(4), 305–313 (1988).
  • Fried PA, Watkinson B, Dillon RF, Dulberg CS. Neonatal neurological status in a low-risk population after prenatal exposure to cigarettes, marijuana, and alcohol. J. Dev. Behav. Pediatr.8(6), 318–326 (1987).
  • Fried PA, O’Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol. Teratol.9(2), 79–85 (1987).
  • Bingham CR, Shope JT, Tang X. Drinking behavior from high school to young adulthood: differences by college education. Alcohol Clin. Exp. Res.29(12), 2170–2180 (2005).
  • Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet. Gynecol.101(2), 374–379 (2003).
  • Phares TM, Morrow B, Lansky A et al. Surveillance for disparities in maternal health-related behaviors – selected states, Pregnancy Risk Assessment Monitoring System (PRAMS), 2000–2001. MMWR Surveill. Summ.53(4), 1–13 (2004).
  • Prescott CA, Neale MC, Corey LA, Kendler KS. Predictors of problem drinking and alcohol dependence in a population-based sample of female twins. J. Stud. Alcohol58(2), 167–181 (1997).
  • Walker DS, Fisher CS, Sherman A, Wybrecht B, Kyndely K. Fetal alcohol spectrum disorders prevention: an exploratory study of women’s use of, attitudes toward, and knowledge about alcohol. J. Am. Acad. Nurse Pract.17(5), 187–193 (2005).
  • Jacobson SW, Carr LG, Croxford J, Sokol RJ, Li TK, Jacobson JL. Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy. J. Pediatr.148(1), 30–37 (2006).
  • Jacobson JL, Jacobson SW, Sokol RJ. Increased vulnerability to alcohol-related birth defects in the offspring of mothers over 30. Alcohol Clin. Exp. Res.20(2), 359–363 (1996).
  • Jacobson JL, Jacobson SW, Sokol RJ, Ager JW Jr. Relation of maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy. Alcohol Clin. Exp. Res.22(2), 345–351 (1998).
  • Jacobson JL, Jacobson SW. Drinking moderately and pregnancy. Effects on child development. Alcohol Res. Health.23(1), 25–30 (1999).
  • May PA, Gossage JP, Brooke LE et al. Maternal risk factors for fetal alcohol syndrome in the Western Cape province of South Africa: a population-based study. Am. J. Public Health95(7), 1190–1199 (2005).
  • Clarren SK, Alvord EC Jr, Sumi SM, Streissguth AP, Smith DW. Brain malformations related to prenatal exposure to ethanol. J. Pediatr.92(1), 64–67 (1978).
  • Astley SJ, Clarren SK. Diagnostic Guide for Fetal Alcohol Syndrome and Related Conditions: The 4-Digit Diagnostic Code (2nd Edition). University of Washington, DC, USA, 1–39 (1999).
  • Astley SJ, Clarren SK. Measuring the facial phenotype of individuals with prenatal alcohol exposure: correlations with brain dysfunction. Alcohol. Alcohol.36(2), 147–159 (2001).
  • Astley SJ, Stachowiak J, Clarren SK, Clausen C. Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population. J. Pediatr.141(5), 712–717 (2002).
  • Ho E, Collantes A, Kapur BM, Moretti M, Koren G. Alcohol and breast feeding: calculation of time to zero level in milk. Biol. Neonate80(3), 219–222 (2001).
  • Koren G. Drinking alcohol while breastfeeding. Will it harm my baby? Can. Fam. Physician48, 39–41 (2002).
  • Little RE, Anderson KW, Ervin CH, Worthington-Roberts B, Clarren SK. Maternal alcohol use during breast-feeding and infant mental and motor development at one year. N. Engl. J. Med.321(7), 425–430 (1989).
  • Little RE, Northstone K, Golding J; ALSPAC Study Team. Alcohol, breastfeeding, and development at 18 months. Pediatrics109(5), E72 (2002).
  • Sulik KK. Genesis of alcohol-induced craniofacial dysmorphism. Exp. Biol. Med. (Maywood)230(6), 366–375 (2005).
  • Jacobson SW, Chiodo LM, Sokol RJ, Jacobson JL. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics109(5), 815–825 (2002).
  • Hamilton DA, Kodituwakku P, Sutherland RJ, Savage DD. Children with fetal alcohol syndrome are impaired at place learning but not cued-navigation in a virtual Morris water task. Behav. Brain Res.143(1), 85–94 (2003).
  • Hamilton DA, Akers KG, Weisend MP, Sutherland RJ. How do room and apparatus cues control navigation in the Morris water task? Evidence for distinct contributions to a movement vector. J. Exp. Psychol. Anim. Behav. Process.33(2), 100–114 (2007).
  • Chasnoff IJ. Drug use and women: establishing a standard of care. Ann. NY Acad. Sci.562, 208–210 (1989).
  • Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N. Engl. J. Med.322(17), 1202–1206 (1990).
  • Chasnoff IJ, Neuman K, Thornton C, Callaghan MA. Screening for substance use in pregnancy: a practical approach for the primary care physician. Am. J. Obstet. Gynecol.184(4), 752–758 (2001).
  • Ostrea EM Jr. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis. Curr. Probl. Pediatr.29(2), 37–56 (1999).
  • Little RE, Uhl CN, Labbe RF, Abkowitz JL, Phillips EL. Agreement between laboratory tests and self-reports of alcohol, tobacco, caffeine, marijuana and other drug use in post-partum women. Soc. Sci. Med.22(1), 91–98 (1986).
  • Alvik A, Haldorsen T, Groholt B, Lindemann R. Alcohol consumption before and during pregnancy comparing concurrent and retrospective reports. Alcohol Clin. Exp. Res.30(3), 510–515 (2006).
  • Gladstone J, Levy M, Nulman I, Koren G. Characteristics of pregnant women who engage in binge alcohol consumption. CMAJ156(6), 789–794 (1997).
  • Day NL, Richardson G, Robles N et al. Effect of prenatal alcohol exposure on growth and morphology of offspring at 8 months of age. Pediatrics85(5), 748–752 (1990).
  • Day NL, Richardson GA, Geva D, Robles N. Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol Clin. Exp. Res.18(4), 786–794 (1994).
  • Bagheri MM, Burd L, Martsolf JT, Klug MG. Fetal alcohol syndrome: maternal and neonatal characteristics. J. Perinat. Med.26(4), 263–269 (1998).
  • Autti-Ramo I, Fagerlund A, Ervalahti N, Loimu L, Korkman M, Hoyme HE. Fetal alcohol spectrum disorders in Finland: clinical delineation of 77 older children and adolescents. Am. J. Med. Genet. A.140(2), 137–143 (2006).
  • Little RE, Asker RL, Sampson PD, Renwick JH. Fetal growth and moderate drinking in early pregnancy. Am. J. Epidemiol.123(2), 270–278 (1986).
  • Streissguth AP, Herman CS, Smith DW. Intelligence, behavior, and dysmorphogenesis in the fetal alcohol syndrome: a report on 20 patients. J. Pediatr.92(3), 363–367 (1978).
  • Streissguth AP, Herman CS, Smith DW. Stability of intelligence in the fetal alcohol syndrome: a preliminary report. Alcohol Clin. Exp. Res.2(2), 165–170 (1978).
  • Singer LT, Arendt R, Minnes S et al. Cognitive and motor outcomes of cocaine-exposed infants. JAMA287(15), 1952–1960 (2002).
  • Kalberg WO, Provost B, Tollison SJ et al. Comparison of motor delays in young children with fetal alcohol syndrome to those with prenatal alcohol exposure and with no prenatal alcohol exposure. Alcohol Clin. Exp. Res.30(12), 2037–2045 (2006).
  • Parnell SE, Dehart DB, Wills TA et al. Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect. Alcohol Clin. Exp. Res.30(10), 1791–1798 (2006).
  • Dunty WC Jr, Zucker RM, Sulik KK. Hindbrain and cranial nerve dysmorphogenesis result from acute maternal ethanol administration. Dev. Neurosci.24(4), 328–342 (2002).
  • Aronson M, Olegard R. Children of alcoholic mothers. Pediatrician14(1–2), 57–61 (1987).
  • Sood B, Delaney-Black V, Covington C et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose–response effect. Pediatrics108(2), E34 (2001).
  • Jacobson SW, Jacobson JL, Sokol RJ, Chiodo LM, Corobana R. Maternal age, alcohol abuse history, and quality of parenting as moderators of the effects of prenatal alcohol exposure on 7.5-year intellectual function. Alcohol Clin. Exp. Res.28(11), 1732–1745 (2004).
  • Mattson SN, Riley EP. Parent ratings of behavior in children with heavy prenatal alcohol exposure and IQ-matched controls. Alcohol Clin. Exp. Res.24(2), 226–231 (2000).
  • Testa M, Quigley BM, Eiden RD. The effects of prenatal alcohol exposure on infant mental development: a meta-analytical review. Alcohol Alcohol.38(4), 295–304 (2003).
  • Kaplan-Estrin M, Jacobson SW, Jacobson JL. Neurobehavioral effects of prenatal alcohol exposure at 26 months. Neurotoxicol. Teratol.21(5), 503–511 (1999).
  • Roebuck TM, Simmons RW, Richardson C, Mattson SN, Riley EP. Neuromuscular responses to disturbance of balance in children with prenatal exposure to alcohol. Alcohol Clin. Exp. Res.22(9), 1992–1997 (1998).
  • Connor PD, Sampson PD, Streissguth AP, Bookstein FL, Barr HM. Effects of prenatal alcohol exposure on fine motor coordination and balance: a study of two adult samples. Neuropsychologia44(5), 744–751 (2006).
  • Gusella JL, Fried PA. Effects of maternal social drinking and smoking on offspring at 13 months. Neurobehav. Toxicol. Teratol.6(1), 13–17 (1984).
  • Streissguth AP, Aase JM, Clarren SK, Randels SP, LaDue RA, Smith DF. Fetal alcohol syndrome in adolescents and adults. JAMA265(15), 1961–1967 (1991).
  • Whaley SE, O’Connor MJ, Gunderson B. Comparison of the adaptive functioning of children prenatally exposed to alcohol to a nonexposed clinical sample. Alcohol Clin. Exp. Res.25(7), 1018–1024 (2001).
  • Thomas SE, Kelly SJ, Mattson SN, Riley EP. Comparison of social abilities of children with fetal alcohol syndrome to those of children with similar IQ scores and normal controls. Alcohol Clin. Exp. Res.22(2), 528–533 (1998).
  • Brown RT, Coles CD, Smith IE et al. Effects of prenatal alcohol exposure at school age. II. Attention and behavior. Neurotoxicol. Teratol.13(4), 369–376 (1991).
  • Landesman-Dwyer S, Ragozin AS, Little RE. Behavioral correlates of prenatal alcohol exposure: a four-year follow-up study. Neurobehav. Toxicol. Teratol.3(2), 187–193 (1981).
  • Bearer CF, Moore C, Salvatore A, Lee S, Buck K, Singer L. Meconium FAEE: development of a biological marker. Alcohol Clin. Exp. Res.22(3), 103A (1998).
  • Bearer CF, Lee S, Salvator AE et al. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin. Exp. Res.23(3), 487–493 (1999).
  • Bearer CF, Jacobson JL, Jacobson SW et al. Validation of a new biomarker of fetal exposure to alcohol. J. Pediatr.143(4), 463–469 (2003).
  • Klein J, Karaskov T, Koren G. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther. Drug Monit.21(6), 644–646 (1999).
  • Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J. Chromatogr. B Biomed. Sci. Appl.713(1), 137–146 (1998).
  • Moore C, Jones J, Lewis D, Buchi K. Prevalence of fatty acid ethyl esters in meconium specimens. Clin. Chem.49(1), 133–136 (2003).
  • Moore CM and Lewis D. Fatty acid ethyl esters in meconium: biomarkers for the detection of alcohol exposure in neonates. Clinica Chimica Acta312(1–2), 235–237 (2001).
  • Ostrea EM Jr, Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics89(1), 107–113 (1992).
  • Ostrea EM Jr, Hernandez JD, Bielawski DM et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin. Exp. Res.30(7), 1152–1159 (2006).
  • Gareri J, Brien J, Reynolds J, Koren G. Potential role of the placenta in fetal alcohol spectrum disorder. Paediatr. Drugs11(1), 26–29 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.